FIELD: medicine. SUBSTANCE: method involves applying expressive structure containing promoter functioning in eukaryotic cells and polynucleotide encoding p53. The polynucleotide is located so that it is oriented according to its sense relative to the promoter. EFFECT: enhanced effectiveness in treating the cases of squamous cellular carcinoma. 43 cl, 28 dwg, 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| CEREBRAL CANCER TREATMENT WITH ONCOLYTIC ADENOVIRUS | 2014 |
|
RU2689553C2 |
| RECOVERING VIRUS RELATED TO CANINE PARVOVIRUS-2 FROM RACOON | 2010 |
|
RU2565538C2 |
| MODIFIED DENDRITE CELLS AND THEIR USE IN TREATMENT OF MALIGNANT TUMOURS | 2008 |
|
RU2484132C2 |
| ADENOVIRUS-RECOMBINANT CARRYING ADENOVIRAL VECTOR STRUCTURE (VARIANTS), METHOD FOR RECOVERY FUNCTION OF PROTEIN P53 IN TUMOR CELL WITH DEFICIENCY OF NATURAL P53, METHOD FOR PRODUCING ADENOVIRUS-RECOMBINANT | 1994 |
|
RU2222600C2 |
| MODIFIED DENDRITIC CELLS AND THEIR APPLICATION FOR MALIGNANT TUMOURS TREATMENT | 2013 |
|
RU2644210C2 |
| FLAVIVIRUS WITH BIPARTITE GENOME AND USING IT | 2008 |
|
RU2527891C2 |
| METHODS AND COMPONENTS FOR INDUCTION OF TUMOR- -SPECIFIC CYTOTOXICITY | 1998 |
|
RU2214280C2 |
| MODIFIED DENDRITIC CELLS AND USE THEREOF IN TREATING MALIGNANT TUMOURS | 2017 |
|
RU2711606C2 |
| POLYVALENT VIRAL VECTORS AND SYSTEM FOR PRODUCING THEREOF | 2005 |
|
RU2416646C2 |
| PEPTIDES OF DIRECTED ACTION OF VEGFR-1/NRP-1 | 2008 |
|
RU2488592C2 |
